Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 9,014	$ 3,115
Receivables
Current assets of discontinued operations		102,627
Total current assets	9,014	105,742
Investment in equity method investee	25,000	25,000
TOTAL ASSETS	34,014	130,742
Current liabilities
Accounts payable and accrued liabilities	168,046	63,664
Due to related parties		(100)
Notes Payable Related Party	332,852
Convertible notes payable, net of discount	526,803	161,404
Derivative liability	763,134	262,712
Settlement liability		106,961
Current liabilities of discontinued operations		123,329
Total current liabilities	1,790,835	717,970
Stockholders' deficit
Preferred stock, 10,000,000 shares authorized, $0.0001 par value, 0 and 4,000,000 issued and outstanding		400
Common stock; $0.0001 par value; 100,000,000 shares authorized; 24,789,981 and 17,133,936 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively.	2,479	1,715
Additional paid-in capital	19,542,531	18,570,178
Accumulated deficit	(21,302,031)	(19,159,721)
Total Stockholders' deficit	(1,756,821)	(587,228)
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY	34,014	130,742
Series C Preferred Stock [Member]
Stockholders' deficit
Preferred stock, 10,000,000 shares authorized, $0.0001 par value, 0 and 4,000,000 issued and outstanding	$ 200	$ 200